Matrix proteins from smoke-exposed fibroblasts are pro-proliferative

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Biochemistry

Background:

• Airway remodeling, characterized by increased extracellular matrix (ECM) deposition, impairs lung function in chronic obstructive pulmonary disease (COPD).
• Fibroblasts play a crucial role in ECM production and airway remodeling.

Purpose of the Study:

• To investigate how cigarette smoke extract (CSE) affects ECM deposition by human lung fibroblasts from COPD patients.
• To determine the pro-proliferative and pro-inflammatory effects of CSE-induced ECM on fibroblasts.

Main Methods:

• Human lung fibroblasts from COPD and non-COPD individuals were exposed to CSE and TGF-β1.
• ECM deposition (perlecan, fibronectin, elastin) and cytokine release (IL-8, IL-13) were measured.
• Signaling pathway inhibitors (NF-κB, STAT) were used to identify mechanisms.
• Fibroblast proliferation and cytokine release on deposited ECM were assessed.

Main Results:

• CSE increased fibronectin and perlecan deposition specifically in COPD fibroblasts.
• NF-κB and STAT inhibitors attenuated CSE-induced ECM deposition.
• CSE elevated IL-8 release from COPD fibroblasts, an effect reduced by an NF-κB inhibitor.
• ECM deposited by CSE-stimulated COPD fibroblasts enhanced fibroblast proliferation.

Conclusions:

• CSE alters ECM composition produced by COPD fibroblasts, contributing to airway remodeling.
• The altered ECM promotes fibroblast proliferation, potentially exacerbating airway remodeling in COPD.
• Targeting CSE-induced signaling pathways may offer therapeutic strategies for COPD airway remodeling.